# Risk: __Lack of testing__ (PBN__Risk_543)

## Property: has_RiskSubject

* [general population in areas with limited testing capacity](../Stakeholder/PBN__Stakeholder_1029)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskSource

* [kraemer_effect_2020](../Article/PBN__Article_248)

## Property: has_RiskName

Difficulty in accurately identifying and tracking cases

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskTechnology

* [testing capacity](../Technology/PBN__Technology_907)

## Property: has_RiskOwner

* [government](../Stakeholder/PBN__Stakeholder_73)
* [healthcare authorities](../Stakeholder/PBN__Stakeholder_452)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskDescription

Insufficient testing capacity during the early phase of the epidemic.

## Property: has_RiskISO_Purpose

* [Health and care](../RiskISO/PBN__RiskISO_Impact_3)

## Property: has_RiskMitigation

* [Testing policy](../RiskMitigation/PBN__RiskMitigation_772)
* [Increase testing capacity, improved testing methods](../RiskMitigation/PBN__RiskMitigation_2129)

